Harvard Pulmonary and Critical Care Medicine 2025

Description

56 videos + 49 pdfs, size: 18.8 GB

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures, and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2025 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

🔴 OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

✅ IPF
✅ ARDS
✅ Sarcoidosis
✅ Lung transplantation
✅ Bronchiectasis
✅ Cystic fibrosis
✅ Lung nodules
✅ Lung cancer
✅ Sepsis
✅ Pleural disease
✅ Pneumonia
✅ Tuberculosis
✅ Thromboembolism
✅ Chronic cough
✅ COPD
✅ Asthma
✅ Occupational and environmental lung disease
✅ Interstitial lung disease
✅ GERD
✅ Neurologic issues in the ICU
✅ Sleep-disordered breathing
✅ Post-acute sequelae of COVID-19
✅ Surgical emergencies
✅ Atypical mycobacterial disease
✅ Pulmonary hypertension
✅ Cardiopulmonary disorders
✅ Complications from cardiac arrest
✅ Hypersensitivity pneumonitis
✅ Acute respiratory failure

👨‍⚕️ 🧑🏾‍💻 REASONS TO ATTEND IN 2025

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

✅ The most current guidelines for treating sepsis
✅ Evidence-based treatment of ARDS
✅ State of the art in interventional pulmonology
✅ High-flow oxygen therapy for respiratory failure
✅ Updates on biologics in asthma and other lung diseases
✅ New concepts in the use of vasopressors in septic shock
✅ New drugs and combinations in pulmonary hypertension
✅ New evidence on sedation, analgesia, and early mobility in the ICU
✅ Point-of-care pulmonary ultrasound in the intensive care unit
✅ Lung microbiome: emerging implications for lung health
✅ Emerging evidence for targeted temperature management
✅ Evaluating occupational and environmental lung disease
✅ Steroid-sparing agents for interstitial lung disease
✅ Pulmonary embolus: the latest treatment strategies
✅ State-of-the-art management of the critically ill patient
✅ Guidance to conduct end-of-life discussions
✅ Updates in pulmonary pathology
✅ New treatment options in cystic fibrosis
✅ Handling neurologic and surgical emergencies in the medical ICU
✅ New approaches that improve outcomes for patients with unexplained chronic cough

Participants also have access to expanded question-and-answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

Optional Half-Day Program
(No additional fees apply)

Sleep Medicine for Pulmonologists

This sleep medicine program allows pulmonologists to learn about recent advances in Sleep Medicine and how they impact clinical practice.

This half-day program, offered on Friday afternoon, May 2, is free for participants of Pulmonology and Critical Care Medicine 2025.

Highlights of this practical, interactive educational experience include:

Updates for diagnosis and management of sleep-disordered breathing
State-of-the-art management algorithms
New technologies vs. the “gold standard” polysomnogram
Reimbursement and telemedicine
Improved adherence to therapy

Participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.

OPTIMIZED FOR REMOTE EDUCATION

The 2025 program has been enhanced for distance learning. In addition to being live-streamed, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.

 🗒 Topics:

Day 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.mp4
Day 1 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis.pdf
Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.mp4
Day 1 Cystic Fibrosis Understanding CFTR and New Treatment.pdf
Day 1 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs.mp4
Day 1 Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs.pdf
Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.mp4
Day 1 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD.pdf
Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.mp4
Day 1 Exercise and Cardiopulmonary Disorders Indications and Interpretation.pdf
Day 1 GERD in Pulmonology.mp4
Day 1 GERD in Pulmonology.pdf
Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.mp4
Day 1 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My.pdf
Day 1: Looking Deeper, Patterns and Insights from Chest Radiology.mp4
Day :1 Looking Deeper, Patterns and Insights from Chest Radiology.pptx
Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.mp4
Day 1 Lung Transplantation 2025 Referral, Patient Selection, Lung Allocation, and COVID.pdf
Day 1 Pulmonary Pathology Interstitial Lung Disease.mp4
Day 1 Pulmonary Pathology Interstitial Lung Disease.pdf
Day 1 Q & A Session with Speakers 1.mp4
Day 1 Q & A Session with Speakers 2.mp4
Day 1 Treatment Challenges of Pulmonary Sarcoidosis.mp4
Day 1 Treatment Challenges of Pulmonary Sarcoidosis.pdf
Day 2 After the ICU Post-ICU Care Syndrome and Recovery.mp4
Day 2 After the ICU Post-ICU Care Syndrome and Recovery.pdf
Day 2 Approach to Empiric Antibiotics in the ICU.mp4
Day 2 Approach to Empiric Antibiotics in the ICU.pdf
Day 2 Approach to the Immunocompromised Critically Ill Patient.mp4
Day 2 Approach to the Immunocompromised Critically Ill Patient.pdf
Day 2 ARDS State-of-the-Art Strategies to Protect the Lung.mp4
Day 2 ARDS State-of-the-Art Strategies to Protect the Lung.pdf
Day 2 Fluid Responsiveness.mp4
Day 2 Fluid Responsiveness.pdf
Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.mp4
Day 2 From Ancient Egypt to Balanced Crystalloids Medicine’s Attempts to Manage Sepsis.pdf
Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.mp4
Day 2 Noninvasive Respiratory Support for Acute Respiratory Failure Less May NOT Be Best.pdf
Day 2 Novel Ventilator Modes The Hype and the Reality.mp4
Day 2 Novel Ventilator Modes The Hype and the Reality.pdf
Day 2 Q & A with Speakers 1.mp4
Day 2 Q & A with Speakers 2.mp4
Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).mp4
Day 2 Renal Replacement Therapy in the ICU What and When to Start (or Not).pdf
Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.mp4
Day 2 Sedation, Analgesia, and Early Mobility The State of the Art in 2025.pdf
Day 2 Vasopressors in Septic Shock Old Friends and New.mp4
Day 2 Vasopressors in Septic Shock Old Friends and New.pdf
Day 3 Advanced Cardiac Support in the ICU.mp4
Day 3 Advanced Cardiac Support in the ICU.pdf
Day 3 Common Neurologic Issues in the ICU.mp4
Day 3 Common Neurologic Issues in the ICU.pdf
Day 3 New Approaches to the Unexplained Chronic Cough.mp4
Day 3 New Approaches to the Unexplained Chronic Cough.pdf
Day 3 Occupational and Environmental Lung Disease.mp4
Day 3 Occupational and Environmental Lung Disease.pdf
Day 3 Palliative Care in Advanced Lung Disease.mp4
Day 3 Palliative Care in Advanced Lung Disease.pdf
Day 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.mp4
Day 3 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care.pdf
Day 3 Point-of-Care Ultrasound in the Intensive Care Unit.mp4
Day 3 Point-of-Care Ultrasound in the Intensive Care Unit.pdf
Day 3 Prognosis and Uncertainty in the ICU.mp4
Day 3 Q & A with Speakers 1.mp4
Day 3 Q & A with Speakers 2.mp4
Day 3 Surgical Emergencies in the Medical ICU.mp4
Day 3 Surgical Emergencies in the Medical ICU.pdf
Day 3 The Microbiome and Lung Disease.mp4
Day 3 The Microbiome and Lung Disease.pdf
Day 3 TTM and Neuroprognostication After Cardiac Arrest.mp4
Day 3 TTM and Neuroprognostication After Cardiac Arrest.pdf
Day 4 A Strategic Approach to the Management of Pulmonary Nodules.pdf
Day 4 Aspergillus Lung Disease.mp4
Day 4 Aspergillus Lung Disease.pdf
Day 4 Asthma What’s New in 2025.mp4
Day 4 Asthma What’s New in 2025.pdf
Day 4 COPD 2025.mp4
Day 4 COPD 2025.pdf
Day 4 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond.mp4
Day 4 Interventional Pulmonology in 2025.mp4
Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.mp4
Day 4 New Therapeutics in Lung Disease The Age of Immunotherapy.pdf
Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.mp4
Day 4 Nontuberculous Mycobacterial Disease Navigating the Labyrinth.pdf
Day 4 Pleural Disease 2025 Updates.mp4
Day 4 Pleural Disease 2025 Updates.pdf
Day 4 Q & A with Speakers 1.mp4
Day 4 Q & A with Speakers 2.mp4
Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.mp4
Day 4 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies.pdf
Day 4 Tuberculosis in 2025.mp4
Day 4 Tuberculosis in 2025.pdf
Day 5 Complex Sleep Apnea 2025.pdf
Day 5 Noninvasive Ventilation.pdf
Day 5 Obstructive Sleep Apnea.pdf
Day 5 Pulmonary Embolism An Update.mp4
Day 5 Pulmonary Hypertension Categorization and Evaluation.mp4
Day 5 Pulmonary Hypertension Management.pdf
Day 5 Sleep Diagnostics.pdf
Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.mp4
Day 5 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fit in 2025.pdf
Day 5 Vasculitis and ANCA.mp4
Day 5 Vasculitis and ANCA.pdf
Day 5.mp4
Pulmonary Schedule.pdf